A

Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS

Watchlist Manager
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Watchlist
Price: 547.3 INR 0.66% Market Closed
Market Cap: ₹83.8B

EV/IC

2.4
Current
3%
Cheaper
vs 3-y average of 2.4

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
2.4
=
Enterprise Value
₹59.8B
/
Invested Capital
₹28.7B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
2.4
=
Enterprise Value
₹59.8B
/
Invested Capital
₹28.7B

Valuation Scenarios

Akums Drugs and Pharmaceuticals Ltd is trading below its 3-year average

If EV/IC returns to its 3-Year Average (2.4), the stock would be worth ₹567.05 (4% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-4%
Maximum Upside
+77%
Average Upside
20%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 2.4 ₹547.3
0%
3-Year Average 2.4 ₹567.05
+4%
5-Year Average 2.4 ₹567.05
+4%
Industry Average 4.2 ₹969.63
+77%
Country Average 2.3 ₹526.03
-4%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

In line with most companies in India
Percentile
51st
Based on 2 828 companies
51st percentile
2.4
Low
0 — 1.3
Typical Range
1.3 — 4.2
High
4.2 —
Distribution Statistics
India
Min 0
30th Percentile 1.3
Median 2.3
70th Percentile 4.2
Max 4 185.7

Akums Drugs and Pharmaceuticals Ltd
Glance View

Akums Drugs and Pharmaceuticals Ltd., an unsung hero within India's healthcare sector, crafts its narrative through a robust commitment to pharmaceutical manufacturing. Founded in 2004, this company quietly emerged as a formidable provider of contract drug manufacturing solutions. Instead of marketing its own branded products, Akums positions itself as the silent partner behind many well-known pharmaceutical names, providing vital production services. By offering end-to-end manufacturing, from raw material sourcing to finished product packaging, Akums ensures that pharmaceutical companies can concentrate on their strengths: marketing and distribution. The company thrives on its vast portfolio, which encompasses the manufacture of nearly every form of a pharmaceutical product—be it tablets, capsules, injectables, or topical treatments. Akums drives revenue through partnerships, where it functions as the backbone of production lines for its clients. Utilizing cutting-edge technology and stringent global standards, Akums not only addresses the varied needs of the pharmaceutical industry but also adapts to the ever-evolving demands of healthcare worldwide. This strategic focus on high-quality contract manufacturing fuels its financial success, allowing it to expand facilities and scale operations, while maintaining a discreet presence that underscores its core philosophy: to innovate in service rather than spotlight.

AKUMS Intrinsic Value
479.02 INR
Overvaluation 12%
Intrinsic Value
Price ₹547.3
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett